Madsen, L. S., Parbo, P., Ismail, R., Gottrup, H., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2023). Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease. Neurobiology of Aging, 123, 1-9. https://doi.org/10.1016/j.neurobiolaging.2022.12.006

Leng, F., Hinz, R., Gentleman, S., Hampshire, A., Dani, M., Brooks, D. J. & Edison, P. (2023). Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease. Molecular Psychiatry, 28(3). https://doi.org/10.1038/s41380-022-01878-z

Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P., Nyengaard, J. R., Jacobsen, K. R., Jørgensen, M. M., Holm, I. E., Kristensen, M. L., Alstrup, A. K. O., Hansen, E. S. S., Teunissen, C. E., Breidenbach, L., Droescher, M., Liu, Y., Pedersen, H. S. ... Sørensen, C. B. (2022). A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency. Cell Reports Medicine, 3(9), [100740]. https://doi.org/10.1016/j.xcrm.2022.100740

Kjeldsen, P. L., Parbo, P., Hansen, K. V., Aanerud, J. F. A., Ismail, R., Nissen, P. H., Dalby, R. B., Damholdt, M. F., Borghammer, P. & Brooks, D. J. (2022). Asymmetrical amyloid deposition in preclinical Alzheimer's disease: A PET study. Aging Brain, 2, [100048]. https://doi.org/10.1016/j.nbas.2022.100048

Madsen, L. S., Nielsen, R. B., Parbo, P., Ismail, R., Mikkelsen, I. K., Gottrup, H., Østergaard, L., Brooks, D. J. & Eskildsen, S. F. (2022). Capillary function progressively deteriorates in prodromal Alzheimer’s disease: A longitudinal MRI perfusion study. Aging Brain, 2, [100035]. https://doi.org/10.1016/j.nbas.2022.100035

Al-Absi, A-R., Thambiappa, S. K., Khan, A. R., Glerup, S., Sanchez, C., Landau, A. M. & Nyengaard, J. R. (2022). Df(h22q11)/+ mouse model exhibits reduced binding levels of GABA_A receptors and structural and functional dysregulation in the inhibitory and excitatory networks of hippocampus. Molecular and Cellular Neuroscience, 122, [103769]. https://doi.org/10.1016/j.mcn.2022.103769

Landau, A., Van Camp, N. & Petiet, A. (2022). Editorial: Advanced Imaging Techniques and Imaging Markers of Synaptic Density and Brain Connectivity in Animal Models of Neurological Diseases. Frontiers in Neuroscience, 16(98036). https://doi.org/10.3389/fnins.2022.980368

Sigurdsson, H. P., Yarnall, A. J., Galna, B., Lord, S., Alcock, L., Lawson, R. A., Colloby, S. J., Firbank, M. J., Taylor, J-P., Pavese, N., Brooks, D. J., O'Brien, J. T., Burn, D. J. & Rochester, L. (2022). Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. Movement Disorders, 37(6), 1222-1234. https://doi.org/10.1002/mds.28977

Andersen, K. B., Hansen, A. K., Knudsen, K., Schacht, A. C., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2022). Healthy brain aging assessed with [¹⁸F]FDG and [¹¹C]UCB-J PET. Nuclear Medicine and Biology, 112-113, 52-58. https://doi.org/10.1016/j.nucmedbio.2022.06.007

Horsager, J., Okkels, N., Van Den Berge, N., Jacobsen, J., Schact, A., Munk, O. L., Vang, K., Bender, D., Brooks, D. J. & Borghammer, P. (2022). In vivo vesicular acetylcholine transporter density in human peripheral organs: an [ 18F]FEOBV PET/CT study. EJNMMI research, 12(1), [17]. https://doi.org/10.1186/s13550-022-00889-9

Hvingelby, V. S., Glud, A. N., Sørensen, J. C. H., Tai, Y., Andersen, A. S. M., Johnsen, E., Moro, E. & Pavese, N. (2022). Interventions to improve gait in Parkinson's disease: a systematic review of randomized controlled trials and network meta-analysis. Journal of Neurology, 269(8), 4068–4079 . https://doi.org/10.1007/s00415-022-11091-1

Giorgi, F. S., Martini, N., Lombardo, F., Galgani, A., Bastiani, L., Della Latta, D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi-Allegra, S., Pavese, N. & Fornai, F. (2022). Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. Journal of Neural Transmission, 129(4), 387-394. https://doi.org/10.1007/s00702-022-02486-5

Giorgi, F. S., Lombardo, F., Galgani, A., Hlavata, H., Della Latta, D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., Scalese, M., Bastiani, L., Keilberg, P., De Marchi, D., Fornai, F. & Bonuccelli, U. (2022). Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects. Brain Imaging and Behavior, 16(3), 1077-1087. https://doi.org/10.1007/s11682-021-00562-0

Xu, Z., Anderson, K. N. & Pavese, N. (2022). Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease. Current Neurology and Neuroscience Reports, 22(10), 635-655. https://doi.org/10.1007/s11910-022-01223-5

Horsager, J., Okkels, N., Hansen, A. K., Damholdt, M. F., Andersen, K. H., Fedorova, T. D., Munk, O. L., Danielsen, E. H., Pavese, N., Brooks, D. J. & Borghammer, P. (2022). Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study. Journal of Parkinson's Disease, 12(8), 2493-2506. https://doi.org/10.3233/JPD-223489

Terkelsen, M. H., Hvingelby, V. & Pavese, N. (2022). Molecular Imaging of the GABAergic System in Parkinson’s Disease and Atypical Parkinsonisms. Current Neurology and Neuroscience Reports, 22(12), 867-879. https://doi.org/10.1007/s11910-022-01245-z

Lunde, S. J., Vuust, P., Garza-Villarreal, E. A., Kirsch, I., Møller, A. & Vase, L. (2022). Music-induced analgesia in healthy participants is associated with expected pain levels but not opioid or dopamine-dependent mechanisms. Frontiers in Pain Research, 3, [734999]. https://doi.org/10.3389/fpain.2022.734999

Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V., Lauritsen, J., Pavese, N. & Romero-Ramos, M. (2022). Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies. Journal of Parkinson's Disease, 12(s1), S149-S163. https://doi.org/10.3233/JPD-223245

Chang, N. H. S., Kumakura, Y., Møller, A., Linnet, J., Bender, D., Doudet, D. J., Vafaee, M. S. & Gjedde, A. (2022). On the learning of addictive behavior: Sensation-seeking propensity predicts dopamine turnover in dorsal striatum. Brain Imaging and Behavior, 16(1), 355-365. https://doi.org/10.1007/s11682-021-00509-5

Pineda-Pardo, J. D. S. A., Sánchez-Ferro, Á., Monje, M. H. G., Pavese, N. & Obeso, J. A. (2022). Onset pattern of nigrostriatal denervation in early Parkinson's disease. Brain, 145(3), 1018-1028. https://doi.org/10.1093/brain/awab378

Dai, W., Zhou, H., Møller, A., Wei, P., Hu, K., Feng, K., Han, J., Li, Q. & Liu, X. (2022). Patients with Methamphetamine Use Disorder Show Highly Utilized Proactive Inhibitory Control and Intact Reactive Inhibitory Control with Long-Term Abstinence. Brain sciences, 12(8), [974]. https://doi.org/10.3390/brainsci12080974

Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J. & Amyloid Biomarker Study Group (2022). Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology, 79(3), 228-243. https://doi.org/10.1001/jamaneurol.2021.5216

Steinmüller, J. B., Binda, K. H., Lillethorup, T. P., Søgaard, B., Orlowski, D., Landau, A. M., Bjarkam, C. R., Sørensen, J. C. H. & Glud, A. N. (2022). Quantitative assessment of motor function in minipig models of neurological disorders using a pressure-sensitive gait mat. Journal of Neuroscience Methods, 380, [109678]. https://doi.org/10.1016/j.jneumeth.2022.109678

O’Brien, J. T., Chouliaras, L., Sultana, J., Taylor, J. P., Ballard, C. & on behalf of the RENEWAL Study Group (2022). RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alzheimer's Research and Therapy, 14(1), [169]. https://doi.org/10.1186/s13195-022-01103-7

Hvingelby, V. S., Højholt Terkelsen, M., Johnsen, E. L., Møller, M., Danielsen, E. H., Henriksen, T., Glud, A. N., Tai, Y., Møller Andersen, A. S., Meier, K., Borghammer, P., Moro, E., Sørensen, J. C. H. & Pavese, N. (2022). Spinal cord stimulation therapy for patients with Parkinson's disease and gait problems (STEP-PD): study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial. BMJ Neurology Open, 4(2), [e000333]. https://doi.org/10.1136/bmjno-2022-000333

Lillethorup, T. P., Noer, O., Alstrup, A. K. O., Cristiano Real Gregório, C., Stokholm, K., Thomsen, M., Zaer, H., Orlowski, D., Mikkelsen, T. W., Glud, AN., Nielsen, E. H. T., Schacht, A. C., Winterdahl, M., Brooks, D. J., Sørensen, J. C. H. & Landau, A. (2022). Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs. NeuroToxicology, 91, 166-176. https://doi.org/10.1016/j.neuro.2022.05.006

Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A. & Landau, A. (2022). Synaptic Vesicle Glycoprotein 2A: Features and Functions. Frontiers in Neuroscience, 16, [864514]. https://doi.org/10.3389/fnins.2022.864514

Arjmand, S., Landau, A. M., Varastehmoradi, B., Andreatini, R., Joca, S. & Wegener, G. (2022). The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants. Molecular Psychiatry, 27(8), 3138–3149 . https://doi.org/10.1038/s41380-022-01598-4

Arjmand, S., Wegener, G., Landau, A. M. & Eskelund, A. (2022). Tips and traps for behavioural animal experimentation. Acta Neuropsychiatrica, 34(5), 240-252. https://doi.org/10.1017/neu.2022.4

Lang, A. E., Siderowf, A. D., Macklin, E. A., Poewe, W., Brooks, D. J., Fernandez, H. H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C. M., Postuma, R. B., Simon, D. K., Tolosa, E., Mollenhauer, B., Cedarbaum, J. M., Fraser, K., Xiao, J., Evans, K. C., Graham, D. L. ... SPARK Investigators (2022). Trial of Cinpanemab in Early Parkinson's Disease. The New England Journal of Medicine, 387(5), 408-420. https://doi.org/10.1056/NEJMoa2203395

Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D. J., Martarello, L., Comley, R. A., Chen, L., Schwarz, A. J., Hargreaves, R., Gunn, R. N., Rabiner, E. A. & Matthews, P. M. (2022). Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease. Science Translational Medicine, 14(658), [eabk1051]. https://doi.org/10.1126/scitranslmed.abk1051

Schmidt, C., Gleesborg, C., Schmidt, H., Kvamme, T. L., Lund, T. E., Voon, V. & Møller, A. (2021). A bias towards natural rewards away from gambling cues in gamblers under‐going active treatment. Brain Research, 1764, [147479]. https://doi.org/10.1016/j.brainres.2021.147479

Vibholm, A. K., Dietz, M. J., Beniczky, S., Christensen, J., Højlund, A., Jacobsen, J., Bender, D., Møller, A. & Brooks, D. J. (2021). Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [¹⁸F]GE-179 positron emission tomography. Epilepsia, 62(12), 2899-2908. https://doi.org/10.1111/epi.17074

Knudsen, K., Fedorova, T. D., Horsager, J., Andersen, K. B., Skjærbæk, C., Berg, D., Schaeffer, E., Brooks, D. J., Pavese, N., Van Den Berge, N. & Borghammer, P. (2021). Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes. Journal of Parkinson's Disease, 11(4), 1677-1687. https://doi.org/10.3233/JPD-212761

Pavese, N. (2021). Atypical Parkinsonian Syndromes and Subtypes of Parkinson's Disease. Will a Single Neuroimaging Modality Ever Be Enough? Movement Disorders Clinical Practice, 8(2), 172-174. https://doi.org/10.1002/mdc3.13137

Mullin, S., Stokholm, M. G., Hughes, D., Mehta, A., Parbo, P., Hinz, R., Pavese, N., Brooks, D. J. & Schapira, A. H. (2021). Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease. Movement Disorders, 36(3), 774-779. https://doi.org/10.1002/mds.28375

Lang, A., Siderowf, A., Macklin, E., Poewe, W., Brooks, D., Fernandez, H., Rascol, O., Giladi, N., Stocchi, F., Tanner, C., Postuma, R., Simon, D., Tolosa, E., Mollenhauer, B., Byrne, M., Fraser, K., Xiao, J., Sapir, I., Inra, J. ... Fox, T. (2021). Cinpanemab in Early Parkinson's Disease: Phase 2 SPARK Study Results. Movement Disorders, 36(S1), S180-S181. [408]. https://doi.org/10.1002/mds.28794

Femminella, G. D., Livingston, N. R., Raza, S., van der Doef, T., Frangou, E., Love, S., Busza, G., Calsolaro, V., Carver, S., Holmes, C., Ritchie, C. W., Lawrence, R. M., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E. ... Edison, P. (2021). Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy, 13(1), [47]. https://doi.org/10.1186/s13195-021-00784-w

Binda, K. H., Lillethorup, T. P., Real, C. C., Bærentzen, S. L., Nielsen, M. N., Orlowski, D., Brooks, D. J., Chacur, M. & Landau, A. M. (2021). Exercise protects synaptic density in a rat model of Parkinson's disease. Experimental Neurology, 342, 113741. https://doi.org/10.1016/j.expneurol.2021.113741

Brooks, D. J. (2021). Future Imaging in Dementia. Seminars in Nuclear Medicine, 51(3), 303-308. https://doi.org/10.1053/j.semnuclmed.2020.12.001

Brooks, D. J. (2021). Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism. Neurotherapeutics, 18(2), 753-771. https://doi.org/10.1007/s13311-020-00994-4

Eskildsen, S. F., Iranzo, A., Stokholm, M. G., Stær, K., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Østergaard, L. & Pavese, N. (2021). Impaired cerebral microcirculation in isolated REM sleep behaviour disorder. Brain : a journal of neurology, 144(5), 1498-1508. https://doi.org/10.1093/brain/awab054

Pagano, G., Molloy, S., Bain, P. G., Rabiner, E. A., Ray Chaudhuri, K., Brooks, D. J. & Pavese, N. (2021). Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [¹¹C]-PHNO PET study. Parkinsonism and Related Disorders, 90, 52-56. https://doi.org/10.1016/j.parkreldis.2021.06.025

Thomsen, M., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M. I. T., Romero-Ramos, M., Brooks, D. J. & Landau, A. (2021). In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Journal of Cerebral Blood Flow and Metabolism, 41(4), 819-830. https://doi.org/10.1177/0271678X20931140

Farmen, K., Nissen, S. K., Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E., Pavese, N. & Romero-Ramos, M. (2021). Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proceedings of the National Academy of Sciences of the United States of America, 118(10), [e2020858118]. https://doi.org/10.1073/pnas.2020858118

Vibholm, A. K., Landau, A. M., Møller, A., Jacobsen, J., Vang, K., Munk, O. L., Orlowski, D., Sorensen, J. C. H. & Brooks, D. J. (2021). NMDA receptor ion channel activation detected in vivo with [¹⁸F]GE-179 PET after electrical stimulation of rat hippocampus. Journal of Cerebral Blood Flow and Metabolism, 41(6), 1301-1312. https://doi.org/10.1177/0271678X20954928

Leng, F., Hinz, R., Gentleman, S., Brooks, D. J. & Edison, P. (2021). Neuroinflammation, functional connectivity and structural network integrity in the Alzheimer's spectrum. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(S3), e055970. https://doi.org/10.1002/alz.055970

Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y., Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021). Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia. Schizophrenia Bulletin, 47(5), 1452-1462. https://doi.org/10.1093/schbul/sbaa200

Jost, S. T., Visser-Vandewalle, V., Rizos, A., Loehrer, P. A., Silverdale, M., Evans, J., Samuel, M., Petry-Schmelzer, J. N., Sauerbier, A., Gronostay, A., Barbe, M. T., Fink, G. R., Ashkan, K., Antonini, A., Martinez-Martin, P., Chaudhuri, K. R., Timmermann, L., Dafsari, H. S. & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group (2021). Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. Parkinson's Disease, 7(1), [48]. https://doi.org/10.1038/s41531-021-00174-x

Thomsen, M. B., Ferreira, S. A., Schacht, A. C., Jacobsen, J., Simonsen, M., Betzer, C., Jensen, P. H., Brooks, D. J., Landau, A. M. & Romero-Ramos, M. (2021). PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease, 149, [105229]. https://doi.org/10.1016/j.nbd.2020.105229

Kinnerup, M. B., Sommerauer, M., Damholdt, M. F., Schaldemose, J. L., Ismail, R., Terkelsen, A. J., Stær, K., Hansen, A., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Borghammer, P., Pavese, N., Brooks, D. J. & Nahimi, A. (2021). Preserved noradrenergic function in Parkinson's disease patients with rest tremor. Neurobiology of Disease, 152, [105295]. https://doi.org/10.1016/j.nbd.2021.105295

Xu, Z., Anderson, K. N., Saffari, S. E., Lawson, R. A., Chaudhuri, K. R., Brooks, D. & Pavese, N. (2021). Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study. Journal of Neurology, 268(1), 312-320. https://doi.org/10.1007/s00415-020-10140-x

Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjaerbaek, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J. & Borghammer, P. (2021). Reduced Synaptic Density in Patients with Lewy Body Dementia: An [¹¹C-]UCB-J PET Imaging Study. Movement Disorders, 36(9), 2057-2065. https://doi.org/10.1002/mds.28617

Doppler, C. E. J., Kinnerup, M. B., Brune, C., Farrher, E., Betts, M., Fedorova, T. D., Schaldemose, J. L., Knudsen, K., Ismail, R., Seger, A. D., Hansen, A. K., Stær, K., Fink, G. R., Brooks, D. J., Nahimi, A., Borghammer, P. & Sommerauer, M. (2021). Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease. Brain : a journal of neurology, 144(9), 2732–2744. https://doi.org/10.1093/brain/awab236

Pasquini, J. & Pavese, N. (2021). Striatal dopaminergic denervation and hypomimia in Parkinson's disease. European Journal of Neurology, 28(1), e2-e3. https://doi.org/10.1111/ene.14483

Pasquini, J., Brooks, D. J. & Pavese, N. (2021). The Cholinergic Brain in Parkinson's Disease. Movement Disorders Clinical Practice, 8(7), 1012-1026. https://doi.org/10.1002/mdc3.13319

Kuebler, L., Buss, S., Leonov, A., Ryazanov, S., Schmidt, F., Maurer, A., Weckbecker, D., Landau, A. M., Lillethorup, T. P., Bleher, D., Saw, R. S., Pichler, B. J., Griesinger, C., Giese, A. & Herfert, K. (2021). [¹¹C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates. European Journal of Nuclear Medicine and Molecular Imaging, 48(6), 1759–1772 . https://doi.org/10.1007/s00259-020-05133-x

Stokholm, K., Thomsen, M. B., Phan, J. A., Møller, L. K., Bay-Richter, C., Christiansen, S. H., Woldbye, D. P. D., Romero-Ramos, M. & Landau, A. M. (2021). α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines, 9(12), [1876]. https://doi.org/10.3390/biomedicines9121876

Nicholas, R., Brooks, D. & Owen, D. (2020). 18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis. European journal of nuclear medicine and molecular imaging, 47(10), 2242-2243. https://doi.org/10.1007/s00259-020-04844-5

Huo, W., Angeles, P., Tai, Y. F., Pavese, N., Wilson, S., Hu, M. T. & Vaidyanathan, R. (2020). A Heterogeneous Sensing Suite for Multisymptom Quantification of Parkinson's Disease. I E E E Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1397-1406. https://doi.org/10.1109/TNSRE.2020.2978197

Vibholm, A. K., Landau, A., Alstrup, A. K. O., Jacobsen, J., Hansen, K. V., Munk, O. L., Dietz, M., Orlowski, D., Sorensen, J. C. & Brooks, D. J. (2020). Activation of NMDA receptor ion channels by deep brain stimulation in the pig visualised with [18F]GE-179 PET. Brain Stimulation, 13(4), 1071-1078. https://doi.org/10.1016/j.brs.2020.03.019

Andersen, K. B., Hansen, A. K., Sommerauer, M., Fedorova, T. D., Knudsen, K., Vang, K., Van Den Berge, N., Kinnerup, M., Nahimi, A., Pavese, N., Brooks, D. J. & Borghammer, P. (2020). Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder: A PET study. Parkinsonism & Related Disorders, 75, 63-69. https://doi.org/10.1016/j.parkreldis.2020.05.013

Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A. ... Drzezga, A. (2020). Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurology, 19(11), 951-962. https://doi.org/10.1016/S1474-4422(20)30314-8

Fox, T., Siderowf, A. D., Fernandez, H. H., Tanner, C. M., Postuma, R. B., Simon, D. K., Byrne, M., Lang, A. E., Brooks, D., Rascol, O., Tolosa, E., Poewe, W., Stocchi, F., Mollenhauer, B., Giladi, N., Hirschhorn, B., Cedarbaum, J. M., Nomikos, G., Fanning, L. ... Brys, M. (2020). Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson's Disease (1579). Neurology, 94(15).

Stær, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study. Movement Disorders, 35(S1), S283-S283. https://onlinelibrary.wiley.com/toc/15318257/2020/35/S1

Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., Sommerauer, M., Danielsen, E. H., Bech, E., Kraft, J., Munk, O. L., Hansen, S. D., Pavese, N., Göder, R., Brooks, D. J. ... Borghammer, P. (2020). Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain, 143(10), 3077-3088. https://doi.org/10.1093/brain/awaa238

Mansur, A., Rabiner, E. A., Comley, R. A., Lewis, Y., Middleton, L. T., Huiban, M., Passchier, J., Tsukada, H., Gunn, R. N. & MIND-MAPS Consortium (2020). Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: ¹⁸F-BCPP-EF, ¹¹C-SA-4503, and ¹¹C-UCB-J C-SA-4503, and 11C-UCB-JC-SA-4503, and 11C-UCB-J1. Journal of Nuclear Medicine, 61(1), 96-103. https://doi.org/10.2967/jnumed.119.228080

Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T. D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D. J., Okamura, N., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder. European Journal of Neurology, 27(4), 644-652. https://doi.org/10.1111/ene.14127

Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. (2020). Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease. Movement Disorders Clinical Practice, 7(4), 373-382. https://doi.org/10.1002/mdc3.12938

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21, [660]. https://doi.org/10.1186/s13063-020-04608-4

Stær, K., Iranzo, A., Stokholm, M. G., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder. Parkinsonism & Related Disorders, 81, 89-93. https://doi.org/10.1016/j.parkreldis.2020.10.014

Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A. J., Roncaroli, F., Klein, J. C., Ansorge, O., Allinson, K. S. J., Jaunmuktane, Z., Holton, J. L., Revesz, T., Warner, T. T., Lees, A. J. ... Morris, H. R. (2020). Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology, 77(3), 377-387. https://doi.org/10.1001/jamaneurol.2019.4347

Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U., Pavese, N. & Ceravolo, R. (2020). Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study. Movement Disorders, 35(6), 1028-1036. https://doi.org/10.1002/mds.28008

Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., Drzezga, A., Dubroff, J., Ekmekcioglu, O., Garibotto, V., Herscovitch, P., Kuo, P., Lammertsma, A., Pappata, S., Penuelas, I. ... Law, I. (2020). EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 47(8), 1885-1912. https://doi.org/10.1007/s00259-020-04817-8

Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C., Møller, A. & Chan, R. C. K. (2020). Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Human Brain Mapping, 41(1), 172-184. https://doi.org/10.1002/hbm.24797

Wang, Y. M., Yang, Z. Y., Cai, X. L., Zhou, H. Y., Zhang, R. T., Yang, H. X., Liang, Y. S., Zhu, X. Z., Madsen, K. H., Sørensen, T. A., Møller, A., Wang, Z., Cheung, E. F. C. & Chan, R. C. K. (2020). Identifying Schizo-Obsessive Comorbidity by Tract-Based Spatial Statistics and Probabilistic Tractography. Schizophrenia Bulletin, 46(2), 442-453. https://doi.org/10.1093/schbul/sbz073

Sigurdsson, H., Yarnall, A., Galna, B., Lord, S., Alcock, L., Morris, R., Lawson, R., Colloby, S., Firbank, M., Pavese, N., Brooks, D., O'brien, J., Burn, D. & Rochester, L. (2020). Identifying neural signatures of Parkinson's disease that predict decline in gait and postural control. Movement Disorders, 35(Suppl. S1), S281-S282. https://doi.org/10.1002/mds.28268

Stokholm, M. G., Garrido, A., Tolosa, E., Serradell, M., Iranzo, A., Ostergaard, K., Borghammer, P., Moller, A., Parbo, P., Staer, K., Brooks, D. J., Jose Marti, M. & Pavese, N. (2020). Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers. Journal of Neurology, 267(8), 2296-2300. https://doi.org/10.1007/s00415-020-09830-3

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Brændgaard, H., Gottrup, H., Brooks, D. J., Østergaard, L. & Eskildsen, S. F. (2020). Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 12(1), [e12032]. https://doi.org/10.1002/dad2.12032

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Nicholas, R., Brooks, D. & Owen, D. (2020). In Response to Letter from Fregonara et al. 2019. Molecular Imaging and Biology, 22(1), 13-14. https://doi.org/10.1007/s11307-019-01463-x

Pagano, G., Molloy, S., Bain, P., Rabiner, E., Chaudhuri, K., Brooks, D. & Pavese, N. (2020). Levodopa-induced dyskinesias and substantia nigra dopamine D3 receptor availability in Parkinson's disease. Movement Disorders, 35, S261-S261. https://doi.org/10.1002/mds.28268

Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G. & Fornai, F. (2020). Locus coeruleus modulates neuroinflammation in parkinsonism and dementia. International Journal of Molecular Sciences , 21(22), 1-21. [8630]. https://doi.org/10.3390/ijms21228630

Parbo, P., Madsen, L. S., Ismail, R., Zetterberg, H., Blennow, K., Eskildsen, S. F., Vorup-Jensen, T. & Brooks, D. J. (2020). Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease. Alzheimer's Research & Therapy, 12(1), [3]. https://doi.org/10.1186/s13195-019-0574-0

Staer, K., Iranzo, A., Stokholm, M., Ostergaard, K., Serradell, M., Otto, M., Svendsen, K., Pla, A., Vilas, D., Santamaria, J., Moller, A., Gaig, C., Brooks, D., Borghammer, P., Tolosa, E. & Pavese, N. (2020). Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder. Movement Disorders, 35(Suppl. S1), S283-S283. https://doi.org/10.1002/mds.28268

Miani, A., Di Bernardo, G. A., Højgaard, A. D., Earp, B. D., Zak, P. J., Landau, A. M., Hoppe, J. & Winterdahl, M. (2020). Neonatal male circumcision is associated with altered adult socio-affective processing. Heliyon, 6(11), [e05566]. https://doi.org/10.1016/j.heliyon.2020.e05566

Kinnerup, M., Doppler, C., Farrher, E., Fedorova, T., Schaldemose, J., Knudsen, K., Isamail, R., Hansen, A., Staer, K., Fink, G., Shah, J., Brooks, D., Nahimi, A., Borghammer, P. & Sommerauer, M. (2020). Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson's disease - a PET and MRI multi-modal imaging study. Movement Disorders, 35(Suppl. S1), S251. https://doi.org/10.1002/mds.28268

Thomsen, M. B., Schacht, A. C., Alstrup, A. K. O., Jacobsen, J., Lillethorup, T. P., Bærentzen, S. L., Noer, O., Orlowski, D., Elfving, B., Müller, H. K., Brooks, D. J. & Landau, A. M. (2020). Preclinical PET Studies of [¹¹C]UCB-J Binding in Minipig Brain. Molecular Imaging and Biology, 22(5), 1290-1300. https://doi.org/10.1007/s11307-020-01506-8

Pasquini, J., Ceravolo, R., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2020). Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal ¹²³I-FP-CIT SPECT study. Parkinsonism & Related Disorders, 77, 170-175. https://doi.org/10.1016/j.parkreldis.2019.03.025

Hansen, A. K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2020). Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study. Journal of Parkinson's Disease, 10(1), 161-171. https://doi.org/10.3233/JPD-191774

Ismail, R., Parbo, P., Madsen, L. S., Hansen, A. K., Hansen, K. V., Schaldemose, J. L., Kjeldsen, P. L., Stokholm, M. G., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2020). The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study. Journal of Neuroinflammation, 17(1), [151]. https://doi.org/10.1186/s12974-020-01820-6

Schmidt, C., Skandali, N., Gleesborg, C., Kvamme, T. L., Schmidt, H., Frisch, K., Møller, A. & Voon, V. (2020). The role of dopaminergic and serotonergic transmission in the processing of primary and monetary reward. Neuropsychopharmacology, 45(9), 1490-1497. https://doi.org/10.1038/s41386-020-0702-3

Pavese, N., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. (2020). Traditional Trial and Error versus Neuroanatomic 3-Dimensional Image Software-Assisted Deep Brain Stimulation Programming in Patients with Parkinson Disease. World Neurosurgery, 134, e98-e102. https://doi.org/10.1016/j.wneu.2019.09.106

Landau, A. M., Noer, O., Alstrup, A. K. O., Audrain, H., Wegener, G., Gjedde, A., Doudet, D. J. & Winterdahl, M. (2020). Type of Anaesthetic Influences [11C]MDL100,907 Binding to 5HT2A Receptors in Porcine Brain. Molecular Imaging and Biology, 22(4), 797-804. https://doi.org/10.1007/s11307-020-01476-x

Horsager, J., Knudsen, K., Andersen, K., Skjaerbaek, C., Fedorova, T., Geday, J., Kraft, J., Bech, E., Danielsen, E., Moller, M., Pavese, N., Brooks, D. & Borghammer, P. (2019). "Brain-first" vs. "body-first" Parkinson's disease is determined by RBD-status - a multi-modality imaging study. Movement Disorders, 34(S2), S796-S796. https://www.mdsabstracts.org/abstract/brain-first-vs-body-first-parkinsons-disease-is-determined-by-rbd-status-a-multi-modality-imaging-study/

Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A., Jacobs, A. H. & Partners IMBI Project (2019). A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia, 15(8), 1081-1103. https://doi.org/10.1016/j.jalz.2019.02.004

Ismail, R., Parbo, P., Hansen, K. V., Schaldemose, J. L., Dalby, R. B., Tietze, A., Kjeldsen, P. L., la Cour, S. H., Qvist, P., Gottrup, H., Eskildsen, S. F. & Brooks, D. J. (2019). Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold. Journal of Neuroimaging, 29(4), 499-505. https://doi.org/10.1111/jon.12629

Metaxas, A., Thygesen, C., Kempf, S. J., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M., Audrain, H., Teeling, J. L., Darvesh, S., Brooks, D. J., Larsen, M. R. & Finsen, B. (2019). Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease. Scientific Reports, 9, [15758]. https://doi.org/10.1038/s41598-019-52357-5

Wang, Y., Zou, L., Xie, W., Yang, Z., Zhu, X., Cheung, EFC., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2019). Altered functional connectivity of the default mode network in patients with schizo-obsessive comorbidity: A comparison between schizophrenia and obsessive-compulsive disorder. Schizophrenia Bulletin, 45(1), 199-210. https://doi.org/10.1093/schbul/sbx194

IMBI Brain Imaging Working Group (2019). Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, 327-332. https://doi.org/10.1016/j.dadm.2019.02.004

Møller, A., Rømer Thomsen, K., Brooks, D. J., Mouridsen, K., Blicher, J. U., Hansen, K. V. & Lou, H. C. (2019). Attenuation of dopamine-induced GABA release in problem gamblers. Brain and Behavior, 9(3), [e01239]. https://doi.org/10.1002/brb3.1239

Pasquini, J., Durcan, R., Wiblin, L., Gersel Stokholm, M., Rochester, L., Brooks, D. J., Burn, D. & Pavese, N. (2019). Clinical implications of early caudate dysfunction in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 90(10), 1098-1104. https://doi.org/10.1136/jnnp-2018-320157

McGinnity, C. J., Årstad, E., Beck, K., Brooks, D. J., Coles, J. P., Duncan, J. S., Galovic, M., Hinz, R., Hirani, E., Howes, O. D., Jones, P. A., Koepp, M. J., Luo, F., Riaño Barros, D. A., Singh, N., Trigg, W. & Hammers, A. (2019). Comment on " In Vivo [18F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates". ACS Chemical Neuroscience, 10(1), 768-772. https://doi.org/10.1021/acschemneuro.8b00246

Sridharan, S., Raffel, J., Nandoskar, A., Record, C., Brooks, D., Owen, D., Sharp, D., Muraro, P., Gunn, R. & Nicholas, R. (2019). Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [ ¹⁸F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Multiple Sclerosis Journal, 21(5), 935-944. https://doi.org/10.1007/s11307-019-01323-8

Hvilsom, A. S. T., Lillethorup, T. P., Iversen, P., Doudet, D. J., Wegener, G. & Landau, A. M. (2019). Cortical and striatal serotonin transporter binding in a genetic rat model of depression and in response to electroconvulsive stimuli. European Neuropsychopharmacology, 29(4), 493-500. https://doi.org/10.1016/j.euroneuro.2019.02.009

Fernandes, H. M., Cabral, J., van Hartevelt, T. J., Lord, L. D., Gleesborg, C., Møller, A., Deco, G., Whybrow, P. C., Petrovic, P., James, A. C. & Kringelbach, M. L. (2019). Disrupted brain structural connectivity in Pediatric Bipolar Disorder with psychosis. Scientific Reports, 9(1), [13638]. https://doi.org/10.1038/s41598-019-50093-4

Álvarez-Martos, I., Møller, A. & Ferapontova, E. E. (2019). Dopamine Binding and Analysis in Undiluted Human Serum and Blood by the RNA-Aptamer Electrode. ACS Chemical Neuroscience, 10(3), 1706-1715. https://doi.org/10.1021/acschemneuro.8b00616

Schubert, J. J., Veronese, M., Marchitelli, L., Bodini, B., Tonietto, M., Stankoff, B., Brooks, D. J., Bertoldo, A., Edison, P. & Turkheimer, F. E. (2019). Dynamic ¹¹C-PIB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis. Journal of Nuclear Medicine, 60(10), 1452-1460. https://doi.org/10.2967/jnumed.118.223834

Landau, A., Alstrup, A. K. O., Noer, O., Winterdahl, M., Audrain, H., Møller, A., Videbech, P., Wegener, G., Gjedde, A. & Doudet, D. J. (2019). Electroconvulsive stimulation differentially affects [¹¹C]MDL100,907 binding to cortical and subcortical 5HT_2A receptors in porcine brain. Journal of Psychopharmacology, 33(6), 714-721. [269881119836212]. https://doi.org/10.1177/0269881119836212

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K. ... Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 20(1), [191]. https://doi.org/10.1186/s13063-019-3259-x

Venkataraman, A. V., Mansur, A., Huiban, M., Passchier, J., Rowe, J. B., Tsukada, H., Brooks, D., Gunn, R. N., Matthews, P. M., Rabiner, E. A. & MINDMAPS Consortium (2019). Evaluation of mitochondrial and synaptic function in Alzheimer's disease (AD): a [F-18]BCPP-EF, [C-11]SA4503 and [C-11]UCB-J PET study. Journal of Cerebral Blood Flow and Metabolism, 39(Suppl. 1), 121-122.

Nielsen, R. B., Parbo, P., Ismail, R., Dalby, R., Tietze, A., Braendgaard, H., Gottrup, H., Brooks, D. J., Ostergaard, L. & Eskildsen, S. F. (2019). Impaired perfusion and capillary distribution of blood in mild cognitive impairment: Relation to oxygenation and amyloid load. Journal of Cerebral Blood Flow and Metabolism, 39(1, suppl.), 147. [PA00-A28]. https://doi.org/10.1177/0271678X19851017

Metaxas, A., Thygesen, C., Briting, S. R. R., Landau, A., Darvesh, S. & Finsen, B. (2019). Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients. Frontiers in Cellular Neuroscience, 13, [538]. https://doi.org/10.3389/fncel.2019.00538

Pavese, N. (2019). Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for? Parkinsonism and Related Disorders, 58, 1-2. https://doi.org/10.1016/j.parkreldis.2018.12.013

Mollenhauer, B., Caspell-Garcia, C. J., Coffey, C. S., Taylor, P., Singleton, A., Shaw, L. M., Trojanowski, J. Q., Frasier, M., Simuni, T., Iranzo, A., Oertel, W., Siderowf, A., Weintraub, D., Seibyl, J., Toga, A. W., Tanner, C. M., Kieburtz, K., Chahine, L. M., Marek, K. ... PPMI Study (2019). Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Movement Disorders, 34(9), 1354-1364. https://doi.org/10.1002/mds.27806

Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T., Hinz, R., Brooks, D. J. & Edison, P. (2019). Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology, 92(12), E1331-E1343. https://doi.org/10.1212/WNL.0000000000007133

van Eimeren, T., Antonini, A., Berg, D., Bohnen, N., Ceravolo, R., Drzezga, A., Höglinger, G. U., Higuchi, M., Lehericy, S., Lewis, S., Monchi, O., Nestor, P., Ondrus, M., Pavese, N., Peralta, M. C., Piccini, P., Pineda-Pardo, J. Á., Rektorová, I., Rodríguez-Oroz, M. ... MDS Neuroimaging Study Group and the JPND Working Group ASAP-SynTau (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, 301-309. https://doi.org/10.1016/j.dadm.2019.01.011

Metaxas, A., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M. & Finsen, B. (2019). Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease. Alzheimer's Research & Therapy, 11(1), [38]. https://doi.org/10.1186/s13195-019-0491-2

Best, L., Ghadery, C., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease. Current Neurology and Neuroscience Reports, 19(5), [24]. https://doi.org/10.1007/s11910-019-0934-y

Ghadery, C., Best, L. A., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases. Current Neurology and Neuroscience Reports, 19(7), [38]. https://doi.org/10.1007/s11910-019-0951-x

Khan, A. N., Bronstein, A., Bain, P., Pavese, N. & Nandi, D. (2019). Pedunculopontine and Subthalamic Nucleus Stimulation Effect on Saccades in Parkinson Disease. World Neurosurgery, 126, e219-e231. https://doi.org/10.1016/j.wneu.2019.02.014

Durcan, R., Wiblin, L., Lawson, R. A., Khoo, T. K., Yarnall, A. J., Duncan, G. W., Brooks, D. J., Pavese, N., Burn, D. J. & ICICLE-PD Study Group (2019). Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease. European Journal of Neurology, 26(7), 979-985. https://doi.org/10.1111/ene.13919

Stuart, S., Lawson, R. A., Yarnall, A. J., Nell, J., Alcock, L., Duncan, G. W., Khoo, T. K., Barker, R. A., Rochester, L., Burn, D. J. & ICICLE-PD Study Grp (2019). Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. Movement Disorders, 34(11), 1690-1698. https://doi.org/10.1002/mds.27813

Tilley, B. S., Smith, C., Pavese, N. & Attems, J. (2019). Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration. BMJ Case Reports, 12(3), [e228305]. https://doi.org/10.1136/bcr-2018-228305

Wang, Y. M., Cai, X. L., Zhang, R. T., Wang, Y., Madsen, K. H., Sørensen, T. A., Møller, A., Cheung, E. F. C. & Chan, R. C. K. (2019). Searchlight classification based on Amplitude of Low Frequency Fluctuation and functional connectivity in individuals with obsessive-compulsive symptoms. Cognitive Neuropsychiatry, 24(5), 322-334. https://doi.org/10.1080/13546805.2019.1658575

Winterdahl, M., Noer, O., Orlowski, D., Schacht, A. C., Jakobsen, S., Alstrup, A. K. O., Gjedde, A. & Landau, A. (2019). Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain. Scientific Reports, 9(1), [16918]. https://doi.org/10.1038/s41598-019-53430-9

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Edginton, T., Hinz, R., Win, Z., Brooks, D. J. & Edison, P. (2019). Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects. Journal of Alzheimer's Disease, 70(2), 455-465. https://doi.org/10.3233/JAD-181168

Jabbari, E., Woodside, J., Tan, M. M. X., Pavese, N., Bandmann, O., Ghosh, B. C. P., Massey, L. A., Capps, E., Warner, T. T., Lees, A. J., Revesz, T., Holton, J. L., Williams, N. M., Grosset, D. G. & Morris, H. R. (2019). The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Movement Disorders, 34(9), 1307-1314. https://doi.org/10.1002/mds.27786

Glud, A. N., Jakobsen, S., Landau, A., Alstrup, A. K. O. & Sorensen, J. C. (2019). Visualization of intrathecal delivery by PET-imaging. Journal of Neuroscience Methods, 317, 45-48. https://doi.org/10.1016/j.jneumeth.2019.02.003

Kuebler, D., Waechter, T., Cabanel, N., Su, Z., Turkheimer, F. E., Dodel, R., Brooks, D. J., Oertel, W. H. & Gerhard, A. (2019). Widespread microglial activation in multiple system atrophy. Movement Disorders, 34(4), 564-568. https://doi.org/10.1002/mds.27620

Woitalla, D., Dunac, A., Safavi, A., Ceravolo, M. G., Gomez Esteban, J. C., Pavese, N., Asgharnejad, M., Joeres, L., Schuller, J. C. & Chaudhuri, K. R. (2018). A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease. Expert Opinion on Pharmacotherapy, 19(9), 937-945. https://doi.org/10.1080/14656566.2018.1480721

Bertelsen, F., Landau, A. M., Vase, K. H., Jacobsen, J., Scheel-Krüger, J. & Møller, A. (2018). Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [C-11]Ro15-4513 microPET study. Brain Research, 1680, 110-114. https://doi.org/10.1016/j.brainres.2017.12.018

Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W-P., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P. & Jensen, P. H. (2018). Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Reports, 19(5), [e44617]. https://doi.org/10.15252/embr.201744617

Wang, Y-M., Zou, L-Q., Xie, W-L., Yang, Z-Y., Zhu, X-Z., Cheung, E. F. C., Sørensen, T. A., Møller, A. & Chan, R. C. K. (2018). Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity. Psychiatry Research, 276, 65-72. https://doi.org/10.1016/j.pscychresns.2018.03.009

Lim, N. K-H., Moestrup, V. T. S., Zhang, X., Wang, W-A., Møller, A. & Huang, F-D. (2018). An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice. Journal of Visualized Experiments, 133, [e56774]. https://doi.org/10.3791/56774

Jansen, W. J., Ossenkoppele, R., Tijms, B. M., Fagan, A. M., Hansson, O., Klunk, W. E., van der Flier, W. M., Villemagne, V. L., Frisoni, G. B., Fleisher, A. S., Lleó, A., Mintun, M. A., Wallin, A., Engelborghs, S., Na, D. L., Chételat, G., Molinuevo, J. L., Landau, S. M., Mattsson, N. ... Amyloid Biomarker Study Group (2018). Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. J A M A Psychiatry, 75(1), 84-95. https://doi.org/10.1001/jamapsychiatry.2017.3391

Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. B. (2018). Automated chin EMG analysis for quantification of REM sleep without atonia. Clinical Neurophysiology, 129(Supplement 1), e76. [F26]. https://doi.org/10.1016/j.clinph.2018.04.189

Sommerauer, M., Hansen, A. K., Parbo, P., Fedorova, T. D., Knudsen, K., Frederiksen, Y., Nahimi, A., Barbe, M. T., Brooks, D. J. & Borghammer, P. (2018). Decreased noradrenaline transporter density in the motor cortex of Parkinson's disease patients. Movement Disorders, 33(6), 1006-1010. https://doi.org/10.1002/mds.27411

Parbo, P., Ismail, R., Sommerauer, M., Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H., Eskildsen, S. F., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2018). Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study. Neurobiology of Disease, 117, 211-216. https://doi.org/10.1016/j.nbd.2018.06.004

Gejl, M., Gjedde, A., Brock, B., Møller, A., van Duinkerken, E., Haahr, H. L., Hansen, C. T., Chu, P-L., Stender-Petersen, K. L. & Rungby, J. (2018). Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial. Diabetologia, 61(3), 551-561. https://doi.org/10.1007/s00125-017-4502-1

Landau, A. M., Alstrup, A. K. O., Audrain, H., Jakobsen, S., Simonsen, M., Møller, A., Videbech, P. B., Wegener, G., Gjedde, A. & Doudet, D. J. (2018). Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy. Journal of Cerebral Blood Flow and Metabolism, 38(5), 881-887. https://doi.org/10.1177/0271678X17705260

Sommerauer, M., Fedorova, T. D., Hansen, A. K., Knudsen, K., Otto, M., Jeppesen, J., Frederiksen, Y., Blicher, J. U., Geday, J., Nahimi, A., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2018). Evaluation of the noradrenergic system in Parkinson's disease; an 11C-MeNER PET and neuromelanin MRI study. Brain, 141(2), 496-504. https://doi.org/10.1093/brain/awx348

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Parbo, P., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2018). Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder. Neurobiology of Disease, 115, 9-16. https://doi.org/10.1016/j.nbd.2018.02.017

Strafella, A. P., Bohnen, N. I., Pavese, N., Vaillancourt, D. E., van Eimeren, T., Politis, M., Tessitore, A., Ghadery, C., Lewis, S. & IPMDS‐Neuroimaging Study Group (2018). Imaging Markers of Progression in Parkinson's Disease. Movement Disorders Clinical Practice, 5(6), 586-596. https://doi.org/10.1002/mdc3.12673

Lillethorup, T. P., Glud, A. N., Landeck, N., Alstrup, A. K. O., Jakobsen, S., Vang, K., Doudet, D. J., Brooks, D. J., Kirik, D., Hinz, R., Sorensen, J. C. & Landau, A. M. (2018). In vivo quantification of glial activation in minipigs overexpressing human alpha-synuclein. Synapse, 72(12), [22060]. https://doi.org/10.1002/syn.22060

Knudsen, K., Fedorova, T. D., Hansen, A. K., Sommerauer, M., Otto, M., Svendsen, K. B., Nahimi, A., Stokholm, M. G., Pavese, N., Beier, C. P., Brooks, D. J. & Borghammer, P. (2018). In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurology, 17(7), 618-628. https://doi.org/10.1016/S1474-4422(18)30162-5

Minett, T., Su, L., Mak, E., Williams, G., Firbank, M., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. & O'Brien, J. T. (2018). Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study. Journal of Neurology, 265(7), 1528-1539. https://doi.org/10.1007/s00415-018-8873-0

Lillethorup, T. P., GLUD, AN., Alstrup, A. K. O., Noer, O., Nielsen, E. H. T., Schacht, A. C., Landeck, N., Kirik, D., Orlowski, D., Sørensen, J. C. H., Doudet, D. J. & Landau, A. (2018). Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs. Scientific Reports, 8, [15715]. https://doi.org/10.1038/s41598-018-34084-5

Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J. & Edison, P. (2018). Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain, 141, 2740-2754. https://doi.org/10.1093/brain/awy188

Chaudhuri, K. R., Poewe, W. & Brooks, D. (2018). Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features. Movement Disorders, 33(6), 909-919. https://doi.org/10.1002/mds.27386

Zou, L-Q., Zhou, H-Y., Zhuang, Y., van Hartevelt, T. J., Lui, S. S. Y., Cheung, E. F. C., Møller, A., Kringelbach, M. L. & Chan, R. C. K. (2018). Neural responses during the anticipation and receipt of olfactory reward and punishment in human. Neuropsychologia, 111, 172-179. https://doi.org/10.1016/j.neuropsychologia.2018.02.003

Pavese, N. & Tai, Y. F. (2018). Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism. Movement Disorders Clinical Practice, 5(2), 131-140. https://doi.org/10.1002/mdc3.12590

Lillethorup, T. P., Glud, A. N., Alstrup, A. K. O., Mikkelsen, T. W., Nielsen, E. H. T., Zaer, H., Doudet, D. J., Brooks, D. J., Sørensen, J. C. H., Orlowski, D. & Landau, A. M. (2018). Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs. Experimental Neurology, 303, 142-152. https://doi.org/10.1016/j.expneurol.2018.02.005

Jeppesen, J., Otto, M., Frederiksen, Y., Hansen, A. K., Fedorova, T. D., Knudsen, K., Nahimi, A., Brooks, D. J., Borghammer, P. & Sommerauer, M. (2018). Observations on muscle activity in REM sleep behavior disorder assessed with a semi-automated scoring algorithm. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 129(3), 541-547. https://doi.org/10.1016/j.clinph.2017.12.029

Maxan, A., Mason, S., Saint-Pierre, M., Smith, E., Ho, A., Harrower, T., Watts, C., Tai, Y., Pavese, N., Savage, J. C., Tremblay, M-È., Gould, P., Rosser, A. E., Dunnett, S. B., Piccini, P., Barker, R. A. & Cicchetti, F. (2018). Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology, 84(6), 950-956. https://doi.org/10.1002/ana.25354

Xu, Z., Arbizu, J. & Pavese, N. (2018). PET Molecular Imaging in Atypical Parkinsonism. International Review of Neurobiology, 142, 3-36. https://doi.org/10.1016/bs.irn.2018.09.001

Alstrup, A. K. O., Munk, O. L., Landau, A. M. & Lillethorup, T. P. (2018). PET radioligand injection for pig neuroimaging. Scandinavian Journal of Laboratory Animal Science, 44(2), 1-5.

Lee, J. Y., Lao-Kaim, N. P., Pasquini, J., Deuschl, G., Pavese, N. & Piccini, P. (2018). Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis. Parkinsonism and Related Disorders, 51, 101-104. https://doi.org/10.1016/j.parkreldis.2018.02.039

Fan, Z., Dani, M., Femminella, G. D., Wood, M., Calsolaro, V., Veronese, M., Turkheimer, F., Gentleman, S., Brooks, D. J., Hinz, R. & Edison, P. (2018). Parametric mapping using spectral analysis for C-11-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. European Journal of Nuclear Medicine and Molecular Imaging, 45(8), 1432-1441. https://doi.org/10.1007/s00259-018-3984-5

Thevathasan, W., Debu, B., Aziz, T., Bloem, B. R., Blahak, C., Butson, C., Czernecki, V., Foltynie, T., Fraix, V., Grabli, D., Joint, C., Lozano, A. M., Okun, M. S., Ostrem, J., Pavese, N., Schrader, C., Tai, C-H., Krauss, J. K., Moro, E. & Movement Disorders Society PPN DBS Working Groupin collaboration with the World Society for Stereotactic and Functional Neurosurgery (2018). Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review. Movement Disorders, 33(1), 10-20. https://doi.org/10.1002/mds.27098

Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., Frisoni, G. B., Ivanoiu, A., Chételat, G., Resende de Oliveira, C., Rodrigue, K. M., Kornhuber, J., Wallin, A., Klimkowicz-Mrowiec, A., Kandimalla, R. ... Ossenkoppele, R. (2018). Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia, 14(7), 913-924. https://doi.org/10.1016/j.jalz.2018.02.009

Xu, Z., Anderson, K., Lawson, R., Brooks, D. J. & Pavese, N. (2018). Progression of sleep disorders spectrum in Parkinson's Disease: A 5 year clinical longitudinal study. Movement Disorders, 33, S761-S762.

Pasquini, J., Ceravolo, R., Qamhawi, Z., Lee, J-Y., Deuschl, G., Brooks, D. J., Bonuccelli, U. & Pavese, N. (2018). Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study. Brain, 141(3), 811-821. https://doi.org/10.1093/brain/awx376

Edison, P. & Brooks, D. J. (2018). Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. Journal of Alzheimer's Disease, 64(s1), S339-S351. https://doi.org/10.3233/JAD-179929

McGinnity, C. J., Barros, D. A. R., Trigg, W., Brooks, D. J., Hinz, R., Duncan, J. S., Koepp, M. J. & Hammers, A. (2018). Simplifying [ ¹⁸F]GE-179 PET: are both arterial blood sampling and 90-min acquisitions essential? EJNMMI research, 8, [46]. https://doi.org/10.1186/s13550-018-0396-2

Ismail, R., Hansen, A. K., Parbo, P., Brændgaard, H., Gottrup, H., Brooks, D. J. & Borghammer, P. (2018). The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease. International Journal of Alzheimer's Disease, 2018, 6852303. [6852303]. https://doi.org/10.1155/2018/6852303

Pavese, N. & the Parkinson's Progression Markers Initiative (2018). The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort. Annals of clinical and translational neurology, 5(12), 1460-1477. https://doi.org/10.1002/acn3.644

Martis, L-S., Tran, T. P., Bouzinova, E., Christiansen, S. L., Møller, A., Holmes, M. C. & Wiborg, O. (2018). The effect of rat strain and stress exposure on performance in touchscreen tasks. Physiology & Behavior, 184, 83-90. https://doi.org/10.1016/j.physbeh.2017.11.010

Helmich, R. C., Vaillancourt, D. E. & Brooks, D. J. (2018). The future of brain imaging in Parkinson's disease. Journal of Parkinson's Disease, 8(s1), S47-S51. https://doi.org/10.3233/JPD-181482

Yousif, N., Mace, M., Pavese, N., Borisyuk, R., Nandi, D. & Bain, P. (2017). A Network Model of Local Field Potential Activity in Essential Tremor and the Impact of Deep Brain Stimulation. PLOS Computational Biology, 13(1), e1005326. https://doi.org/10.1371/journal.pcbi.1005326

Januliene, D., Andersen, J. L., Nielsen, J. A., Quistgaard, E. M., Hansen, M., Strandbygaard, D., Moeller, A., Petersen, C. M., Madsen, P. & Thirup, S. S. (2017). Acidic Environment Induces Dimerization and Ligand Binding Site Collapse in the Vps10p Domain of Sortilin. Structure, 25(12), 1809-1819.e3. [12]. https://doi.org/10.1016/j.str.2017.09.015

Fan, Z., Brooks, D. J., Okello, A. & Edison, P. (2017). An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain, 140, 792-803. https://doi.org/10.1093/brain/aww349

Stokholm, M. G., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., Møller, A., Gaig, C., Brooks, D. J., Tolosa, E. & Pavese, N. (2017). Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurology, 16(10), 789-796. https://doi.org/10.1016/S1474-4422(17)30173-4

Arshad, Q., Bonsu, A., Lobo, R., Fluri, A-S., Sheriff, R., Bain, P., Pavese, N. & Bronstein, A. M. (2017). Biased numerical cognition impairs economic decision-making in Parkinson's disease. Annals of clinical and translational neurology, 4(10), 739-748. https://doi.org/10.1002/acn3.449

Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O. M., Eskildsen, S. F., Lund, T. E., Tietze, A., Edison, P., Pavese, N., Stokholm, M. G., Borghammer, P., Hinz, R., Aanerud, J. & Brooks, D. J. (2017). Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease. Brain, 140(7), 2002-2011. https://doi.org/10.1093/brain/awx120

Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., Eskildsen, S. F. & Østergaard, L. (2017). Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. Alzheimer's & Dementia, 13(10), 1143-1153. https://doi.org/10.1016/j.jalz.2017.02.007

Firbank, M. J., Yarnall, A. J., Lawson, R. A., Duncan, G. W., Khoo, T. K., Petrides, G. S., O'Brien, J. T., Barker, R. A., Maxwell, R. J., Brooks, D. J. & Burn, D. J. (2017). Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of Neurology, Neurosurgery and Psychiatry, 88(4), 310-316. https://doi.org/10.1136/jnnp-2016-313918

Politis, M., Wilson, H., Wu, K., Brooks, D. J. & Piccini, P. (2017). Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients. NeuroImage: Clinical, 16, 455-460. https://doi.org/10.1016/j.nicl.2017.08.013

Fedorova, T. D., Seidelin, L. B., Knudsen, K., Schacht, A. C., Geday, J., Pavese, N., Brooks, D. J. & Borghammer, P. (2017). Decreased intestinal acetylcholinesterase in early Parkinson disease; An 11C-donepezil PET study. Neurology, 88(8). https://doi.org/10.1212/WNL.0000000000003633

Phan, J-A., Stokholm, K., Zareba-Paslawska, J., Jakobsen, S., Vang, K., Gjedde, A., Landau, A. M. & Romero-Ramos, M. (2017). Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Scientific Reports, 7(1), [6363]. https://doi.org/10.1038/s41598-017-06724-9

Pilegaard, A. M., Berendt, M., Holst, P., Møller, A. & McEvoy, F. J. (2017). Effect of Skull Type on the Relative Size of Cerebral Cortex and Lateral Ventricles in Dogs. Frontiers in Veterinary Science, 4, 30. https://doi.org/10.3389/fvets.2017.00030

Januliene, D., Manavalan, A., Ovesen, P. L., Pedersen, K. M., Thirup, S., Nykjær, A. & Moeller, A. (2017). Hidden Twins: SorCS Neuroreceptors Form Stable Dimers. Journal of Molecular Biology, 429(19), 2907-2917. https://doi.org/10.1016/j.jmb.2017.08.006

Borghammer, P., Knudsen, K., Fedorova, T. D. & Brooks, D. J. (2017). Imaging Parkinson's disease below the neck. Parkinson's Disease, 3, 15. https://doi.org/10.1038/s41531-017-0017-1

Hansen, A. K., Damholdt, M. F., Fedorova, T. D., Knudsen, K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J. & Borghammer, P. (2017). In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography. Movement Disorders, 32(6), 922-927. https://doi.org/10.1002/mds.26961

Bertelsen, F., Møller, A., Folloni, D., Drasbek, K. R., Scheel-Krüger, J. & Landau, A. M. (2017). Increased GABA_A receptor binding in amygdala after prenatal administration of valproic acid to rats. Acta Neuropsychiatrica, 29(5), 309-3014. https://doi.org/10.1017/neu.2016.59

Gredal, H., Thomsen, B. B., Boza-Serrano, A., Garosi, L., Rusbridge, C., Anthony, D., Møller, A., Finsen, B., Deierborg, T., Lambertsen, K. L. & Berendt, M. (2017). Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke. NeuroReport, 28(3), 134-140. https://doi.org/10.1097/WNR.0000000000000728

Peraza, L. R., Nesbitt, D. J., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., Kaiser, M., Firbank, M. J., O'Brien, J. T., Barker, R. A., Brooks, D. J., Burn, D. J. & Taylor, J-P. (2017). Intra-and Inter-Network Functional Alterations in Parkinson's Disease with Mild Cognitive Impairment. Human Brain Mapping, 38(3), 1702-1715. https://doi.org/10.1002/hbm.23499

Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Mollenhauer, B., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. J. & O'Brien, J. T. (2017). Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiology of Aging, 55, 78-90. https://doi.org/10.1016/j.neurobiolaging.2017.03.012

Hansen, A. K., Brooks, D. J. & Borghammer, P. (2017). MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-017-1143-1

Strafella, A. P., Bohnen, N. I., Perlmutter, J. S., Eidelberg, D., Pavese, N., Van Eimeren, T., Piccini, P., Politis, M., Thobois, S., Ceravolo, R., Higuchi, M., Kaasinen, V., Masellis, M., Peralta, M. C., Obeso, I., Pineda-Pardo, J. Á., Cilia, R., Ballanger, B., Niethammer, M. ... IPMDS-Neuroimaging Study Group (2017). Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders, 32(2), 181-192. https://doi.org/10.1002/mds.26907